ACET vs. ETON

In the year-to-date period, ACET achieves a -50.27% return, which is significantly lower than ETON's 30.11% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Adicet Bio, Inc. (ACET) and Eton Pharmaceuticals Inc (ETON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ACET Sharpe Ratio is -0.89, which is lower than the ETON Sharpe Ratio of 6.09. The chart below compares the historical Sharpe Ratios of ACET and ETON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ACET nor ETON has paid dividends to shareholders.

The maximum ACET drawdown since its inception was -99.69%, which is greater than ETON's maximum drawdown of -79.94%. Use the drawdown chart below to compare losses from any high point for ACET and ETON. For additional features, visit the drawdowns tool.

Adicet Bio, Inc. (ACET) has a higher volatility of 41.57% compared to Eton Pharmaceuticals Inc (ETON) at 16.32%. This indicates that ACET's price experiences larger fluctuations and is considered to be riskier than ETON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Adicet Bio, Inc. and Eton Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.